New guidelines for Cancer Center Support Grants will enable centers to apply for salary support for clinical investigators.
New benchmark for CCSG award funding will be lowered from 20 percent of NCI research base to 15 percent, the program’s “reality ratio,” Karen Antman tells NCAB.
Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.
Broad Institute wins NIH grant for first national SNP genotyping center.
Cancer center investigators share Nobel Prizes in medicine, chemistry.
Funding opportunities listed.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - George Weiner: Cancer centers are special, as are site visits in CCSG review
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- $180M in NCI grants have been terminated by Trump administration, systematic review finds